The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases
The CpG island methylator phenotype (CIMP) in stage III colon cancer (CRC) has been associated with improved survival after treatment with adjuvant irinotecan-based chemotherapy. In this analysis, we determine...
Clinical Epigenetics 2017 9:46
Published on: 2 May 2017